COVID-19 Vaccine
HALIX Signs Agreement With AstraZeneca For Commercial Manufacture Of COVID-19 Vaccine
HALIX
PR-M11-20-031Dec 10, 2020
Agreement
PPD Signs New Service Agreement with Pfizer
PPD clinical research business of Thermo Fisher Scientific
PR-M08-20-NI-08Aug 04, 2020
COVID-19 Vaccine
SGS Signs Analytical Testing Agreement with AstraZeneca for COVID-19 Vaccine Candidate
SGS Life Science Services
PR-M07-20-NI-28Jul 17, 2020
COVID-19 Vaccine
Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate
Catalent
PR-M04-20-NI-044-1583Apr 30, 2020
Agreement
Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates
Lonza
PR-M10-19-NI-006Oct 04, 2019
Agreement
Vertex Announces New Access Agreement with Scottish Government for ORKAMBI® (lumacaftor/ivacaftor) and SYMKEVI® (tezacaftor/ivacaftor)
Vertex
PR-M09-19-NI-041Sep 16, 2019
3D Bioprinting
iBio Inks 3D Bioprinting Agreement
iBio, Inc.
PR-M08-19-NI-058Aug 20, 2019
Contract Manufacturing
Avid Bioservices Enters into Contract Manufacturing Agreements with New and Existing Customers
Avid Bioservices
PR-M07-19-NI-030Jul 12, 2019
Emergex Signs an R&D Agreement with IMCB to Develop a Vaccine for the Emerging Threat of Hand, Foot & Mouth Disease
Emergex Vaccines Holding Limited
PR-M07-19-NI-031Jul 12, 2019
Agreement
Eisai and Empatica Enter an Agreement to Co-Promote the Embrace2 Device for People Living With Epilepsy in the U.S.
Eisai
PR-M02-19-NI-048Feb 21, 2019
Acquisition
Johnson & Johnson Announces Agreement to Acquire Auris Health, Inc.
Johnson & Johnson
PR-M02-19-NI-036Feb 15, 2019
Agreement
UPMC Health Plan Announces Innovative, Value-Based Agreement with AstraZeneca
UPMC Health Plan
PR-M01-19-NI-084Jan 29, 2019
Biosimilars
U.S. Department of Veterans Affairs Signs Contract with Merck for its Remicade Biosimilar
Nice Insight
PAO-M10-18-NI-010Oct 12, 2018
Agreement
Glenmark Pharmaceuticals and Harbour BioMed Sign Agreement for Greater China to Develop GBR 1302, a First-in-Class Bispecific Antibody for Treatment of HER2-Positive Cancers
Glenmark Pharmaceuticals
PR-M08-18-NI-050Aug 13, 2018
Preferred Provider
Leiters and Avanos Medical Announce Preferred Provider Agreement
Leiters
PR-M07-18-NI-054Jul 17, 2018
Animal Health
LEUKOCARE and Boehringer Ingelheim Enter into a Long-Term Agreement in the Field of Animal Health
Boehringer Ingelheim
PR-M04-18-NI-53Apr 16, 2018
Probiotics
J&J Involved in Probiotics Development Program
Emilie Branch
Pharma's Almanac
PR-M03-18-NI-100Mar 29, 2018
Licensing
Protein Science to Advance Through LenioBio and Dow AgroSciences License Agreement
LenioBio GmbH
PR-M03-18-NI-064Mar 19, 2018
Distribution
Grifols Announces New Agreement with Henry Schein to Distribute Normal Saline Solution in the U.S.
Grifols
PR-M03-18-NI-018Mar 06, 2018
Agreement
Abarca, Amgen Enter Outcomes-Based Agreement For Repatha® (evolocumab)
Abarca
PR-M02-18-NI-103Feb 28, 2018